Skip to main content
OpenTrials
Completed

NCT Number: NCT01715389

Evaluation of a Shared Decision Making Portal for Pediatric Asthma

This pilot intervention study will test the feasibility and acceptability and explore the outcomes of a primary care-based shared decision making (SDM) electronic medical record (EMR)-based portal that provides education, elicits and tracks patients/families' treatment concerns and goals, assesses symptoms and asthma control over time, and provides decision support to clinicians and families.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

6 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Parents/legal guardians of children aged 6-12 with persistent asthma, currently receiving chronic maintenance therapy, cared for at a study practice, with consistent access to a computer with an internet connection where they feel comfortable accessing MyChart (patient portal)
  • Clinician at study site

Exclusion criteria

  • parents non-english speaking
  • child's primary care provider at the time of enrollment is a pediatric resident
  • not meeting inclusion criteria

Treatment and study plan

MyAsthma Patient Portal

Other

Parents in the intervention group will use the MyAsthma Patient Portal to receive enhanced educational information on asthma and its treatment, identify concerns and goals related to asthma treatment, track progress toward goals and management of concerns monthly, and track asthma symptoms monthly.

Clinicians seeing intervention families at office visits will have access to information from the portal including concerns, goals, progress toward goals, and tracking of asthma symptoms.

Primary outcomes

  1. Acceptability of the intervention to parents and clinicians

    Time frame: 24 months

    Parents and clinicians will be asked a series of open-ended questions regarding themes including satisfaction, acceptability and unintended consequences of using the portal for intervention subjects and using MyChart in general for control subjects. Subjects will also be asked a series of Likert-scaled questions related to satisfaction.

Secondary outcomes

  1. Shared decision making

    Time frame: Baseline

    Joint participation in decision-making will be measured by the Observing Parent Involvement (OPTION) scale.

  2. Parent Activation

    Time frame: 0 months, 3 months, 6 months

    Parent activation will be measured by the Parent Patient Activation Measure (PPAM).

  3. Goal Attainment

    Time frame: 0 months, 3 months, 6 months then Monthly

    Parents will identify one or more goals at the study start. Progress toward the goal(s) will be assessed at 3 and 6 month follow-up using Likert-scaled items for the control group, and monthly through use of the portal for the intervention group.

  4. Asthma-Related Quality of Life

    Time frame: 0 months, 6 months

    Asthma-related quality of life will be measured using The Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF)

  5. Asthma Control

    Time frame: 0 months, 6 months

    Asthma control will be assessed using the Pediatric Asthma Control Tool (PACT)

  6. Asthma-related Utilization

    Time frame: 3 months, 6 months

    Utilization will be measured by parent report and chart review by the research team of the following:

    Any primary care or subspecialty outpatient encounters relevant to asthma care, asthma-specific acute primary care visits or Urgent Care Center visits, asthma-specific Emergency Room visits, asthma-specific hospital admissions.

  7. Asthma Medication Adherence/Receipt

    Time frame: 6 months

    Prescribed medications for the treatment and management of asthma Type and number of prescriptions for asthma

  8. Feasibility of Recruitment

    Time frame: 24 months

    The feasibility of recruitment will be assessed by examining the proportion of all families contacted who meet enrollment criteria and the proportion of families meeting enrollment criteria who enroll.

  9. Feasibility of Follow-up

    Time frame: 24 months

    The feasibility of follow-up will be assessed by the proportion of enrolled families who complete each study measure.

  10. Feasibility of Portal Use

    Time frame: 24 months

    The feasibility of portal use will be assessed by the level of research team/other outside support needed.

Sponsors and collaborators

Lead sponsor

Children's Hospital of Philadelphia

Other

Registry information

Important dates

Study start
2012
Primary completion
2014
Study completion
2015
First posted
Oct 29, 2012
Registry last updated
Jun 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.